Mitchell H. Gold
2019
In 2019, Mitchell H. Gold earned a total compensation of $1.6M as Executive Chairman and Chief Executive Officer at Nivalis Therapeutics, a 49% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $218,250 |
|---|---|
| Option Awards | $852,681 |
| Salary | $485,000 |
| Total | $1,555,931 |
Gold received $852.7K in option awards, accounting for 55% of the total pay in 2019.
Gold also received $218.3K in non-equity incentive plan and $485K in salary.
Rankings
In 2019, Mitchell H. Gold's compensation ranked 7,147th out of 13,971 executives tracked by ExecPay. In other words, Gold earned more than 48.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,147 out of 13,971 | 49th |
Division Manufacturing | 2,751 out of 5,701 | 52nd |
Major group Chemicals And Allied Products | 1,017 out of 2,200 | 54th |
Industry group Drugs | 862 out of 1,886 | 54th |
Industry Pharmaceutical Preparations | 635 out of 1,398 | 55th |
Source: SEC filing on May 5, 2020.
Gold's colleagues
We found two more compensation records of executives who worked with Mitchell H. Gold at Nivalis Therapeutics in 2019.